Keros Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -12.34M-45.36M-58.74M-104.68M-152.99M-187.35M
Depreciation and Depletion 0.21M0.28M0.38M0.67M0.81M1.23M
Share-based Compensation 0.06M4.10M11.72M18.68M28.76M34.87M
Gains from Investment Securities 0.70M-0.05M15.42M1.34M5.74M
Cash from Operations -16.00M-36.89M-62.15M-70.06M-124.51M-160.87M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.23M0.33M0.52M0.94M1.55M1.82M
Depreciation & Amortization (CF) 0.21M0.28M0.38M0.67M0.81M1.23M
Change in Working Capital
Change in Receivables 18.00M-18.00M0.14M2.60M
Change in Account Payables 1.31M0.06M1.49M-0.41M1.61M-0.25M
Change in Accured Expenses 1.19M2.59M2.65M5.32M5.26M2.95M
Other Working Capital Changes -10.00M1.47M1.55M3.32M9.28M10.22M
Investing Activities
Capital Expenditures 0.27M0.29M1.02M1.24M2.46M1.93M
Cash from Investing Activities -0.27M-0.29M-1.02M-1.24M-2.46M-1.93M
Financing Activities
Other financing activities 0.42M0.10M0.09M0.09M0.17M
Cash from Financing Activities 0.01M296.04M28.55M120.31M178.96M391.82M
Additional items
Change in Cash -16.25M258.86M-34.62M49.01M51.98M229.02M
Free Cash Flow -16.27M-37.19M-63.17M-71.30M-126.97M-162.80M
Net Cash Flow -16.25M258.86M-34.62M49.01M51.98M229.02M